Q/C Technologies Inc (QCLS)

$2.99 -0.09 (-2.92%)
Market Cap 10.51M
Revenue (ttm) 0.00
Net Income (ttm) -23.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 108,523
Avg Vol 2,173,898
Day's Range N/A - N/A
Shares Out 2.98M
Stochastic %K 37%
Beta 2.05
Analysts Strong Buy
Price Target N/A

Company Profile

Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog o...

Industry: Computer Hardware
Sector: Technology
Phone: 856 848 8698
Address:
1185 Avenue of the Americas, Suite 249, New York, United States
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Nov. 14 at 6:35 PM
$QCLS I really hope Altucher is just waiting for a full trading week to start promoting this (you know, like the one we had last Monday before they inexplicably moved the announcement). He doesn't strike me as the type of person who works for free and given his tranched warrant agreement he can go ahead and start ASAP kty
0 · Reply
Stad
Stad Nov. 14 at 6:27 PM
$QCLS • If Q/C Technologies successfully transitions and its new technology/business takes off, given the tiny size the upside could be large in percentage terms. • The low book value basis and relatively low price to book might offer a potential “deep-value if things go right” micro cap, low float 💰
0 · Reply
Stad
Stad Nov. 14 at 6:12 PM
$QCLS bought more @ 2.99 🐂 💵🤑
0 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Nov. 14 at 6:06 PM
$QCLS you know I gotta say the literal handful of ppl holding the majority of this and holding it down are taking a major risk. I have the liquidity to wait them out but most ppl do not. What if someone gets forced out of their position and is ass out and desperate and goes up to their HQ for payback? Is an extra 1-5% really worth that? In the words of Bud Fox to Gordon Gekko "How much is enough? How many yachts can you water ski behind?" Don't these ppl have any sense of self-preservation, if not for themselves then for the families that depend on them? I mean all is fair in a Hunger Games-style arena where ppl are literally starving to death but why not settle for most of it instead of putting your neck out in the relentless pursuit of all of it? Sick.
0 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Nov. 14 at 5:25 PM
$QCLS intraday is pathetic. What the hell was the point of moving the vote announce to the end of the week if they weren't working on catalysts to announce with it? All they had to do was stream themselves saying "for" and ending it; would have taken 2 mins. I guess it was an attempt to shake out the impatient and the insolvent? They already own about 95% of this thing; are they really so greedy as to stall and sink it to get another percent or two? Look at this picture. We're established and recognized in the sector and sitting at three fking dollars? Should be double digits at the very least by now. Disgusting pathetic greed. Suck my balls.
1 · Reply
albotrader
albotrader Nov. 14 at 5:15 PM
$QCLS today pretty much confirmed that the majority of the float is locked by insiders and whales which wasn’t surprising at all. My only question right now is when are we going to get some clarification on what’s happening with the bio assets and what direction we are heading in with the LPU. Also want to hear from Altucher and get his thoughts.
0 · Reply
IldijanaMM
IldijanaMM Nov. 14 at 4:03 PM
$QCLS Dude I told you in 4-5 even 6$ they only sell shares 😑 And I know when I will cover here! It’s not up here
0 · Reply
WickedEntry
WickedEntry Nov. 14 at 3:49 PM
$QCLS 10M market cap is fine, they can't let it go sub 10 too much or else it risks being completely written off, id say we are pretty sturdy at 10M floor, but we are tied to the greater market of risk on crypto ai shit so have to wait for that to heat up
0 · Reply
WickedEntry
WickedEntry Nov. 14 at 3:46 PM
$QCLS im at 70-80% loaned out right now guys, making about 750-1 grand per month just holding, amazing
2 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Nov. 14 at 3:43 PM
$QCLS the bitch of this play atm is, they're having it both ways. The cost to borrow and the complete absence of share lending (for me anyway) prevents ppl from generating a nice passive income because shorts are not stupid/suicidal/masochistic enough to bear down on this. But also the company and their newly-hired promoter won't kindly remove the thumbs from their asses and put this thing in gear. So bulls aren't making anything atm and some/many will be liquidated waiting which is all part of their plan.
0 · Reply
Latest News on QCLS
Q/C Technologies Introduces Proprietary qc-LPU100™ Brand of Quantum-Class Laser Processing Units

Oct 30, 2025, 9:15 AM EDT - 15 days ago

Q/C Technologies Introduces Proprietary qc-LPU100™ Brand of Quantum-Class Laser Processing Units

Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives

Oct 16, 2025, 9:15 AM EDT - 4 weeks ago

Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

Sep 25, 2025, 9:15 AM EDT - 7 weeks ago

Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

Sep 24, 2025, 9:15 AM EDT - 7 weeks ago

TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Sep 17, 2025, 9:24 AM EDT - 2 months ago

TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Sep 8, 2025, 9:15 AM EDT - 2 months ago

TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

TNF Pharmaceuticals Announces Closing of $7 Million Private Placement

Sep 4, 2025, 9:15 AM EDT - 2 months ago

TNF Pharmaceuticals Announces Closing of $7 Million Private Placement

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

Sep 2, 2025, 9:20 AM EDT - 2 months ago

PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

PMCB

TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

Sep 2, 2025, 9:15 AM EDT - 2 months ago

TNF Pharmaceuticals Secures Exclusive Global Rights to Innovative Light Speed Computing Accelerator for Use in Cryptocurrency Applications

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

Aug 28, 2025, 9:15 AM EDT - 2 months ago

TNF Pharmaceuticals Announces Reverse Stock Split For Nasdaq Listing Compliance

TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

Aug 19, 2025, 5:20 PM EDT - 3 months ago

TNF Pharmaceuticals Strengthens Financial Position for Growth and Value Creation

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

Jun 24, 2025, 9:15 AM EDT - 5 months ago

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists

May 8, 2025, 9:20 AM EDT - 6 months ago

TNF Pharmaceuticals and Renova Health Report Positive Results in Identifying Targets for Treating TNF-Driven Inflammation in Patients Receiving GLP-1 Agonists

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

Apr 22, 2025, 9:15 AM EDT - 7 months ago

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025

Apr 16, 2025, 9:15 AM EDT - 7 months ago

TNF Pharmaceuticals Delivers Platform Presentation of Oral TNF-Alpha Inhibitor Isomyosamine at British Geriatrics Society's Spring Meeting 2025

TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia

Mar 17, 2025, 9:15 AM EDT - 8 months ago

TNF Pharmaceuticals Delivers Podium Presentation of Novel Oral TNF-Alpha Inhibitor at Premier International Conference on Frailty and Sarcopenia

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025

Mar 5, 2025, 9:00 AM EST - 9 months ago

TNF Pharmaceuticals to Host Investor Conference Call and Webcast Featuring Clinical Scientific Updates on Thursday, March 6, 2025

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

Feb 25, 2025, 9:20 AM EST - 9 months ago

TNF Pharmaceuticals Initiates Phase 2b Clinical Trial of First Oral TNF-Alpha Inhibitor

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment

Jan 29, 2025, 9:15 AM EST - 10 months ago

TNF Pharmaceuticals Launches Study Series Aimed at Preserving Lean Muscle Mass During GLP-1 Weight Loss Treatment

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

Jan 15, 2025, 9:15 AM EST - 10 months ago

TNF Pharmaceuticals Announces Positive Clinical Data Supporting Clinical Trial Expansion

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

Dec 19, 2024, 9:15 AM EST - 11 months ago

TNF Pharmaceuticals Announces Trial to Explore Effects of Lead Candidate in Sarcopenia/Frailty Induced by GLP-1 Weight Loss Drugs

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

Dec 9, 2024, 9:00 AM EST - 1 year ago

TNF Pharmaceuticals Presents Statistically Significant Phase 2a Trial Results for Novel Sarcopenia/Frailty Treatment at Prestigious International Conference

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

Oct 2, 2024, 9:10 AM EDT - 1 year ago

TNF Pharmaceuticals Announces Strategic Equity Investment Priced at a Premium to Market

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline

Aug 21, 2024, 9:00 AM EDT - 1 year ago

TNF Pharmaceuticals Prepares to Advance Lead Clinical Program Targeting Age-Related Decline

PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Nov. 14 at 6:35 PM
$QCLS I really hope Altucher is just waiting for a full trading week to start promoting this (you know, like the one we had last Monday before they inexplicably moved the announcement). He doesn't strike me as the type of person who works for free and given his tranched warrant agreement he can go ahead and start ASAP kty
0 · Reply
Stad
Stad Nov. 14 at 6:27 PM
$QCLS • If Q/C Technologies successfully transitions and its new technology/business takes off, given the tiny size the upside could be large in percentage terms. • The low book value basis and relatively low price to book might offer a potential “deep-value if things go right” micro cap, low float 💰
0 · Reply
Stad
Stad Nov. 14 at 6:12 PM
$QCLS bought more @ 2.99 🐂 💵🤑
0 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Nov. 14 at 6:06 PM
$QCLS you know I gotta say the literal handful of ppl holding the majority of this and holding it down are taking a major risk. I have the liquidity to wait them out but most ppl do not. What if someone gets forced out of their position and is ass out and desperate and goes up to their HQ for payback? Is an extra 1-5% really worth that? In the words of Bud Fox to Gordon Gekko "How much is enough? How many yachts can you water ski behind?" Don't these ppl have any sense of self-preservation, if not for themselves then for the families that depend on them? I mean all is fair in a Hunger Games-style arena where ppl are literally starving to death but why not settle for most of it instead of putting your neck out in the relentless pursuit of all of it? Sick.
0 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Nov. 14 at 5:25 PM
$QCLS intraday is pathetic. What the hell was the point of moving the vote announce to the end of the week if they weren't working on catalysts to announce with it? All they had to do was stream themselves saying "for" and ending it; would have taken 2 mins. I guess it was an attempt to shake out the impatient and the insolvent? They already own about 95% of this thing; are they really so greedy as to stall and sink it to get another percent or two? Look at this picture. We're established and recognized in the sector and sitting at three fking dollars? Should be double digits at the very least by now. Disgusting pathetic greed. Suck my balls.
1 · Reply
albotrader
albotrader Nov. 14 at 5:15 PM
$QCLS today pretty much confirmed that the majority of the float is locked by insiders and whales which wasn’t surprising at all. My only question right now is when are we going to get some clarification on what’s happening with the bio assets and what direction we are heading in with the LPU. Also want to hear from Altucher and get his thoughts.
0 · Reply
IldijanaMM
IldijanaMM Nov. 14 at 4:03 PM
$QCLS Dude I told you in 4-5 even 6$ they only sell shares 😑 And I know when I will cover here! It’s not up here
0 · Reply
WickedEntry
WickedEntry Nov. 14 at 3:49 PM
$QCLS 10M market cap is fine, they can't let it go sub 10 too much or else it risks being completely written off, id say we are pretty sturdy at 10M floor, but we are tied to the greater market of risk on crypto ai shit so have to wait for that to heat up
0 · Reply
WickedEntry
WickedEntry Nov. 14 at 3:46 PM
$QCLS im at 70-80% loaned out right now guys, making about 750-1 grand per month just holding, amazing
2 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Nov. 14 at 3:43 PM
$QCLS the bitch of this play atm is, they're having it both ways. The cost to borrow and the complete absence of share lending (for me anyway) prevents ppl from generating a nice passive income because shorts are not stupid/suicidal/masochistic enough to bear down on this. But also the company and their newly-hired promoter won't kindly remove the thumbs from their asses and put this thing in gear. So bulls aren't making anything atm and some/many will be liquidated waiting which is all part of their plan.
0 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Nov. 14 at 3:36 PM
$QCLS I imagine this will play out like CRML did; the supposed pop-day trivialized to frustrate and force out daytraders and short swings then one day out of the blue it starts moving after they've moved on. Market isn't set up for intraday.
0 · Reply
Newtothisting
Newtothisting Nov. 14 at 3:34 PM
$QCLS waited weeks for this meeting for that? No positive news? No catalyst? No sale of old equipment/meds? Nothing?
1 · Reply
Stad
Stad Nov. 14 at 3:30 PM
$QCLS
0 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Nov. 14 at 3:29 PM
$QCLS wow the slingshot is pulled back as far as it can get and they're really going to nothingburger the catalyst and stretch it out for weeks, months, years while retail is forced to sell due to pay living expenses and pop-up incidents and allow them to scoop cheapies? Well game on cocksmokes; I got the rest of my life.
0 · Reply
WickedEntry
WickedEntry Nov. 14 at 3:26 PM
$QCLS notice how fast the vote wen through, most share are owned and controlled by insiders, so they have incentive to move up the price. Expect more catalysts as we dig into Q4
1 · Reply
PostQCLSpaidlendinginfo
PostQCLSpaidlendinginfo Nov. 14 at 3:23 PM
$QCLS yep that was a foregone conclusion as most of the float is controlled by insiders and a few whales; time to unchock the wheels and move this fking thing
1 · Reply
albotrader
albotrader Nov. 14 at 3:22 PM
$QCLS so all we got was that they approved everything?
0 · Reply
SIWCG
SIWCG Nov. 14 at 3:21 PM
$QCLS All approved...
0 · Reply
Palvin
Palvin Nov. 14 at 3:20 PM
$QCLS Crooks!
0 · Reply
IldijanaMM
IldijanaMM Nov. 14 at 3:14 PM
$QCLS @JJBurch try to sell your shares are your all in play when volume is 20k for the day 🤣
0 · Reply
BHWinehouse
BHWinehouse Nov. 14 at 3:13 PM
$QCLS yes, it's live now..
0 · Reply
Palvin
Palvin Nov. 14 at 3:05 PM
$QCLS Is there even a meeting today?!?!?!?
1 · Reply